None listed
Conditions
Interventions
Intervention1: SiddhA Makardhawaj and Arogyavardhini: 100mg, OD and 250mg, BD for 4 weeks
Control Intervention1: Ashwagandha Choorna and Arjuna Choorna: 3g, BD and 3g, BD for 3 weeks
Sponsors
DEPARTMENT OF AYUSH
MINISTRY OF HEALTH & FAMILY WELFARE
GOVERNMENT OF INDIA
INDIA
Eligibility
Inclusion criteria
Inclusion criteria: a) Patient of either sex of age 18-60 years. b) Patient diagnosed with neurological & joint disorder or skin & liver diseases. c) Requires treatment with Siddh makardhwaja and Arogyavardhini vati for a period of 4 weeks or more. d) Patient able to provide written informed consent.
Exclusion criteria
Exclusion criteria: a) Medical history of unstable angina, myocardial infarction, heart failure or stroke within 3 months of the study b) Uncontrolled hypertension (diastolic blood pressure >100 mm Hg) c) Uncontrolled diabetes mellitus. d) ALT and AST > 2 x upper limit of normal ( 40mg/dl) e) Impaired renal function (creatinine ≥2.0 mg/dl) f) Pregnancy/Lactation g) Patients on any ayurvedic drugs during the last 15 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At end of study, the following informations/ outcomes will be generated. Safety status with reference to renal and kidney functions after treatment with ayurvedic rasa aushadhies (Siddh makardhawaj, Arogyavardhini vati). Timepoint: Day 0 day 21, Day 25, Day 49 | — |
Secondary
| Measure | Time frame |
|---|---|
| The blood and urine level of heavy metals (mercury, lead, cadmium and arsenic) after treatment with ayurvedic rasa aushadhies (Siddh makardhawaj, Arogyavardhini vati) and their correlation with renal and hepatic function.Timepoint: Day 0 day 21, Day 25, Day 49 | — |
Countries
India
Contacts
Public ContactDR YK GUPTA
AIIMS, New Delhi
Outcome results
None listed